Articles & Newsletters

VIEW ALL » NYC Sightseeing Companies Settle with Federal and State Authorities
March 27, 2015 |
  • Weil-Antitrust / Competition Perspectives
    • The FTC’s Challenge to Verisk’s Acquisition of EagleView: Distinct Customers May Constitute a Distinct Relevant Market
    January 27, 2015 |
  • Benjamin Bauer
    • Supreme Court of Canada Allows Challenged Merger to Proceed on Efficiency Grounds
    January 27, 2015 |
  • Weil-Antitrust / Competition Perspectives

    • Cartel Watch

    VIEW ALL » Cartel Watch (Volume 4, Issue 1)
    August 30, 2016 |
  • Alex Shear
    • Cartel Watch (Volume 3, Issue 5)
    December 23, 2015 |
  • Joseph Adamson
  • Neil Rigby
    • Cartel Watch (Volume 3, Issue 4)
    October 5, 2015 |
  • Weil-Antitrust / Competition Perspectives

    • IP Insights

    VIEW ALL » DOJ, FTC Issue Proposed Update of Antitrust-IP Guidelines
    August 31, 2016 |
  • Adam Hemlock
  • John Scribner
  • Lisa Madalone
    • VIEW ALL » Antitrust Liability and Unilateral Refusals to License Intellectual Property
    July 8, 2016 |
  • Adam Hemlock
  • John Scribner
  • Lisa Madalone
    • VIEW ALL » Potential Antitrust Implications of Grantbacks
    March 29, 2016 |
  • Adam Hemlock
  • John Scribner
  • Lisa Madalone

    • Alerts

    VIEW ALL » Hedge Fund Settles HSR Act Violation, Setting Record $11 Million Fine
    July 15, 2016 |
  • Vadim Brusser
  • Jonathan Cheng
  • Alexis Brown-Reilly
    • DOJ’s Suit Against Hedge Fund for HSR Act Violations May Clarify the HSR “Investment-Only” Exemption
    April 7, 2016 |
  • Vadim Brusser
  • Jonathan Cheng
  • Alexis Brown-Reilly
    • FTC Requires Divestitures in Generic Pharmaceutical Markets Even Though the Target Had Exited the Markets
    March 7, 2016 |
  • Kristin Sanford

    • All News Announcements

    VIEW ALL » Weil Honored at 2016 LMG Life Sciences Awards
    September 27, 2016
    Weil Served as Antitrust Counsel to Allergan in its Divestiture of Global Generics Business to Teva Pharmaceuticals
    August 3, 2016
    Weil’s New York Antitrust/Competition Practice Ranked as “Highly Recommended” in Global Competition Review Survey
    April 22, 2016